iRobot Reports Second-Quarter 2025 Financial Results
"Our second quarter performance fell short of our expectations, due to persistent market headwinds and delays in scaling production and sales of our new products," said
"As our Board of Directors continues its review of strategic alternatives for our business, we remain steadfast in executing our iRobot Elevate strategy and delivering the trusted products our customers value."
Second Quarter 2025 Financial Results ( in millions, except per share amounts and percentages)
|
Q2 2025 |
Q2 2024 |
Revenue |
|
|
GAAP Gross Margin¹ |
30.0 % |
16.5 % |
Non-GAAP Gross Margin¹ |
30.2 % |
16.7 % |
GAAP Operating Expenses |
|
|
Non-GAAP Operating Expenses |
|
|
GAAP Operating Loss² |
( |
( |
Non-GAAP Operating Loss² |
( |
( |
GAAP Net Loss Per Share³ |
( |
( |
Non-GAAP Net Loss Per Share³ |
( |
( |
|
1) In Q2 2024, GAAP and Non-GAAP gross margin were negatively impacted by an |
|
2) In Q2 2024, GAAP and Non-GAAP operating loss were negatively impacted by the Manufacturing Transition Charge. |
|
3) In Q2 2024, GAAP and Non-GAAP net loss per share were negatively impacted by the Manufacturing Transition Charge, which reduced GAAP and non-GAAP net loss per share by |
Balance Sheet and Operational Highlights
- As of
June 28, 2025 , the Company's cash and cash equivalents totaled$40.6 million , compared with$69.9 million as ofMarch 29, 2025 . As ofJune 28, 2025 , the Company had an additional$36.0 million of restricted cash set aside for future repayment of its term loan, subject to limited ability of the Company to utilize such amount at the discretion of the lenders for the purchase of inventory. - As of
June 28, 2025 , the Company's inventory totaled$88.2 million , representing a 13% reduction from the second quarter of 2024. - In the second quarter of 2025, revenue increased 6% in
Japan , declined 33% in theU.S. and declined 17% in EMEA over the prior-year period. Excluding the unfavorable foreign currency impact,Japan revenue increased 7% and EMEA revenue declined 16% over the prior-year period. - Revenue from mid-tier robots (with an MSRP between
$300 and$499 ) and premium robots (with an MSRP of$500 or more) represented 73% of total robot sales in the second quarter of 2025 versus 76% from the same period last year.
Marketing Highlights
- In July, iRobot introduced its most powerful and intelligent 2-in-1 robot to date, the Roomba® Max 705 Combo Robot + AutoWash™ Dock. Designed for the busiest homes, the Roomba Max 705 Combo delivers a deep, hands-free clean with 175 times more power-lifting suction*, AI-driven technology to avoid clutter left by kids and pets, and a first-of-its-kind roller mop cover that keeps carpets dry.
- For the 11th consecutive year, Roomba was a featured product in Amazon's Prime Day event, which was held
July 8-11 . iRobot was ranked #1, #2 and #3 for the bestselling robot vacuum cleaners during Prime Day. The Company's products received a record number of Prime Day related media mentions in outlets including:Good Morning America ,Better Homes & Gardens , HuffPost,Rolling Stone , GQ, Forbes Vetted, Real Simple and more. - In June, iRobot announced the debut of a multi-platform marketing campaign, its first since 2023. Beginning on
June 16 , television spots featuring the new tagline, "Roomba. Made for This," began airing in theU.S. on premium streaming services including Hulu, Amazon Prime Video, Peacock, Paramount+ and more.
*Performance in spot-clean mode with full battery compared to Roomba® 600 series robots.
Ongoing Strategic Review
As previously announced, iRobot's Board of Directors is conducting a review of strategic alternatives, including, but not limited to, exploring a potential sale or strategic transaction, and refinancing the Company's debt. This review process is ongoing.
The Board has not set a timetable for the conclusion of this review, and there can be no assurance that the exploration of strategic alternatives will result in any transactions or outcomes. The Company does not intend to disclose developments relating to this process until it determines that further disclosure is appropriate or necessary.
The Company remains actively engaged in ongoing collaborative and constructive discussions with its primary lender while the Board continues its strategic review. On
In light of the ongoing strategic review, the Company will not host an earnings conference call or webcast regarding its second quarter 2025 results and has suspended its practice of providing financial guidance.
About iRobot
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold millions of robots worldwide. iRobot's product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Board's review of strategic alternatives for the business; and the Company's business plans and strategies and the anticipated impact thereof. These forward-looking statements are based on the Company's current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the Company's control, and are not guarantees of future results. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company's ability to obtain capital when desired on favorable terms, if at all; (ii) the Company's ability to realize the benefits of its operational restructuring; (iii) the impact of various global conflicts on the Company's business and general economic conditions; (iv) the Company's ability to implement its business strategy; (v) the risk that disruptions from the Company's operational restructuring will harm its business, including current plans and operations; (vi) the ability of the Company to retain and hire skilled personnel; (vii) loss of any key employee; (viii) failure of the Company's primary contract manufacturer to meet the Company's requirements; (ix) legislative, regulatory and economic developments affecting the Company's business; (x) general economic and market developments and conditions; (xi) the evolving legal, regulatory and tax regimes under which the Company operates; (xii) potential business uncertainty, including changes to existing business relationships that could affect the Company's financial performance; (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xiv) current supply chain challenges; (xv) the financial strength of the Company's customers and retailers; (xvi) the impact of any applicable tariffs on goods imported into
|
|||||||
Consolidated Statements of Operations |
|||||||
(in thousands, except per share amounts) |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
For the six months ended |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ 127,558 |
|
$ 166,361 |
|
$ 229,127 |
|
$ 316,375 |
Cost of revenue: |
|
|
|
|
|
|
|
Cost of product revenue |
89,259 |
|
138,895 |
|
168,857 |
|
252,808 |
Restructuring and other |
- |
|
- |
|
1,658 |
|
- |
Total cost of revenue |
89,259 |
|
138,895 |
|
170,515 |
|
252,808 |
|
|
|
|
|
|
|
|
Gross profit |
38,299 |
|
27,466 |
|
58,612 |
|
63,567 |
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
Research and development |
13,766 |
|
23,230 |
|
28,453 |
|
57,108 |
Selling and marketing |
39,003 |
|
39,980 |
|
65,054 |
|
69,696 |
General and administrative |
21,069 |
|
16,926 |
|
40,085 |
|
(36,785) |
Restructuring and other |
1,032 |
|
8,230 |
|
7,206 |
|
22,377 |
Amortization of acquired intangible assets |
145 |
|
168 |
|
280 |
|
339 |
Total operating expenses |
75,015 |
|
88,534 |
|
141,078 |
|
112,735 |
|
|
|
|
|
|
|
|
Operating loss |
(36,716) |
|
(61,068) |
|
(82,466) |
|
(49,168) |
|
|
|
|
|
|
|
|
Other income (expense), net |
13,385 |
|
(8,849) |
|
(27,680) |
|
(12,034) |
|
|
|
|
|
|
|
|
Loss before income taxes |
(23,331) |
|
(69,917) |
|
(110,146) |
|
(61,202) |
Income tax (benefit) expense |
(523) |
|
729 |
|
(65) |
|
837 |
Net loss |
$ (22,808) |
|
$ (70,646) |
|
$ (110,081) |
|
$ (62,039) |
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
Basic |
$ (0.68) |
|
$ (2.41) |
|
$ (3.41) |
|
$ (2.16) |
Diluted |
$ (0.68) |
|
$ (2.41) |
|
$ (3.41) |
|
$ (2.16) |
|
|
|
|
|
|
|
|
Number of shares used in per share calculations: |
|
|
|
|
|
|
|
Basic |
33,410 |
|
29,309 |
|
32,259 |
|
28,740 |
Diluted |
33,410 |
|
29,309 |
|
32,259 |
|
28,740 |
|
|
|
|
|
|
|
|
Stock-based compensation included in above figures: |
|
|
|
|
|
|
|
Cost of revenue |
$ 197 |
|
$ 270 |
|
$ 543 |
|
$ 1,099 |
Research and development |
757 |
|
802 |
|
1,668 |
|
3,699 |
Selling and marketing |
808 |
|
1,163 |
|
1,772 |
|
2,500 |
General and administrative |
2,001 |
|
2,275 |
|
5,093 |
|
5,160 |
Total |
$ 3,763 |
|
$ 4,510 |
|
$ 9,076 |
|
$ 12,458 |
iRobot Corporation |
|||
Condensed Consolidated Balance Sheets |
|||
(unaudited, in thousands) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ 40,568 |
|
$ 134,303 |
Restricted cash |
36,000 |
|
1,259 |
Accounts receivable, net |
56,072 |
|
49,865 |
Inventory |
88,236 |
|
76,029 |
Other current assets |
23,903 |
|
27,046 |
Total current assets |
244,779 |
|
288,502 |
Property and equipment, net |
10,959 |
|
15,835 |
Operating lease right-of-use assets |
12,995 |
|
14,322 |
Deferred tax assets |
10,403 |
|
9,817 |
Goodwill |
182,449 |
|
167,288 |
Intangible assets, net |
3,274 |
|
3,212 |
Other assets |
15,461 |
|
17,161 |
Total assets |
$ 480,320 |
|
$ 516,137 |
|
|
|
|
Liabilities and stockholders' (deficit) equity |
|
|
|
|
|
|
|
Accounts payable |
$ 166,785 |
|
$ 106,367 |
Accrued expenses |
76,859 |
|
100,597 |
Deferred revenue and customer advances |
9,773 |
|
11,280 |
Term loan |
203,186 |
|
- |
Total current liabilities |
456,603 |
|
218,244 |
Term loan |
- |
|
200,604 |
Operating lease liabilities |
19,069 |
|
21,598 |
Other long-term liabilities |
12,340 |
|
14,452 |
Total long-term liabilities |
31,409 |
|
236,654 |
Total liabilities |
488,012 |
|
454,898 |
Stockholders' (deficit) equity |
(7,692) |
|
61,239 |
Total liabilities and stockholders' (deficit) |
$ 480,320 |
|
$ 516,137 |
iRobot Corporation |
|||
Consolidated Statements of Cash Flows |
|||
(unaudited, in thousands) |
|||
|
|
|
|
|
|
|
|
|
For the six months ended |
||
|
|
|
|
Cash flows from operating activities: |
|
|
|
Net loss |
$ (110,081) |
|
$ (62,039) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
Depreciation and amortization |
4,385 |
|
11,116 |
(Gain) loss on equity investment |
(394) |
|
375 |
Stock-based compensation |
9,076 |
|
12,458 |
Provision for inventory excess and obsolescence |
1,015 |
|
11,715 |
Change in fair value of term loan |
2,687 |
|
4,746 |
Debt issuance costs expensed under fair value option |
16,828 |
|
477 |
Deferred income taxes, net |
292 |
|
(1,682) |
Other |
3,112 |
|
(3,858) |
Changes in operating assets and liabilities — (use) source |
|
|
|
Accounts receivable |
(3,735) |
|
9,240 |
Inventory |
(12,816) |
|
35,848 |
Other assets |
5,700 |
|
26,117 |
Accounts payable |
59,428 |
|
(63,875) |
Accrued expenses and other liabilities |
(32,114) |
|
(871) |
Net cash used in operating activities |
(56,617) |
|
(20,233) |
|
|
|
|
Cash flows from investing activities: |
|
|
|
Additions of property and equipment |
- |
|
(118) |
Purchase of investments |
(14) |
|
(46) |
Net cash used in investing activities |
(14) |
|
(164) |
|
|
|
|
Cash flows from financing activities: |
|
|
|
Income tax withholding payment associated with restricted stock vesting |
(257) |
|
(463) |
Proceeds from issuance of common stock, net of issuance costs |
- |
|
17,942 |
Repayment of term loan |
(4,000) |
|
(34,947) |
Payment of debt issuance costs |
- |
|
(477) |
Net cash used in financing activities |
(4,257) |
|
(17,945) |
|
|
|
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
1,914 |
|
853 |
Net decrease in cash, cash equivalents and restricted cash |
(58,974) |
|
(37,489) |
Cash, cash equivalents and restricted cash, at beginning of period |
137,951 |
|
187,887 |
Cash, cash equivalents and restricted cash, at end of period |
$ 78,977 |
|
$ 150,398 |
|
|
|
|
Cash, cash equivalents and restricted cash, at end of period: |
|
|
|
Cash and cash equivalents |
$ 40,568 |
|
$ 108,513 |
Restricted cash |
36,000 |
|
40,543 |
Restricted cash, non-current (included in other assets) |
2,409 |
|
1,342 |
Cash, cash equivalents and restricted cash, at end of period |
$ 78,977 |
|
$ 150,398 |
iRobot Corporation |
|||||||
Supplemental Information |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
For the six months ended |
||||
|
|
|
|
|
|
|
|
Revenue by |
|
|
|
|
|
|
|
|
$ 56,441 |
|
$ 84,364 |
|
$ 97,881 |
|
$ 153,260 |
EMEA |
33,253 |
|
39,894 |
|
66,200 |
|
84,982 |
|
29,424 |
|
27,818 |
|
51,373 |
|
55,536 |
Other |
8,440 |
|
14,285 |
|
13,673 |
|
22,597 |
Total |
$ 127,558 |
|
$ 166,361 |
|
$ 229,127 |
|
$ 316,375 |
|
|
|
|
|
|
|
|
Robot Units Shipped * |
|
|
|
|
|
|
|
2-in-1 |
453 |
|
274 |
|
765 |
|
463 |
Solo and other |
63 |
|
300 |
|
161 |
|
567 |
Total |
516 |
|
574 |
|
926 |
|
1,030 |
|
|
|
|
|
|
|
|
Revenue by Product Category ** |
|
|
|
|
|
|
|
2-in-1 |
$ 100 |
|
$ 76 |
|
$ 165 |
|
$ 132 |
Solo and other |
28 |
|
90 |
|
64 |
|
184 |
Total |
$ 128 |
|
$ 166 |
|
$ 229 |
|
$ 316 |
|
|
|
|
|
|
|
|
Average gross selling prices for robot units |
$ 301 |
|
$ 330 |
|
$ 299 |
|
$ 337 |
|
|
|
|
|
|
|
|
Headcount |
509 |
|
726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* in thousands |
|
|
|
|
|
|
|
** in millions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certain numbers may not total due to rounding |
|
|
|
|
|
|
|
Explanation of Non-GAAP Measures
In addition to disclosing financial results in accordance with
Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Amortization of Acquired Intangible Assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.
Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, costs associated with early termination of contracts, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.
Debt Issuance Costs: Debt issuance costs include various incremental fees paid to third parties and warrants issued in connection with the issuance or amendment of debt.
Income Tax Adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowance based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors' consistent earnings comparison between periods.
|
|||||||
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals |
|||||||
(in thousands, except per share amounts) |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
For the three months ended |
|
For the six months ended |
||||
|
|
|
|
|
|
|
|
GAAP Revenue |
$ 127,558 |
|
$ 166,361 |
|
$ 229,127 |
|
$ 316,375 |
|
|
|
|
|
|
|
|
GAAP Gross Profit |
$ 38,299 |
|
$ 27,466 |
|
$ 58,612 |
|
$ 63,567 |
Stock-based compensation |
197 |
|
270 |
|
543 |
|
1,099 |
Restructuring and other |
- |
|
- |
|
1,658 |
|
- |
Non-GAAP Gross Profit |
$ 38,496 |
|
$ 27,736 |
|
$ 60,813 |
|
$ 64,666 |
GAAP Gross Margin |
30.0 % |
|
16.5 % |
|
25.6 % |
|
20.1 % |
Non-GAAP Gross Margin |
30.2 % |
|
16.7 % |
|
26.5 % |
|
20.4 % |
|
|
|
|
|
|
|
|
GAAP Operating Expenses |
$ 75,015 |
|
$ 88,534 |
|
$ 141,078 |
|
$ 112,735 |
Amortization of acquired intangible assets |
(145) |
|
(168) |
|
(280) |
|
(339) |
Stock-based compensation |
(3,566) |
|
(4,240) |
|
(8,533) |
|
(11,359) |
Net merger, acquisition and divestiture (expense) income |
(4,768) |
|
43 |
|
(5,718) |
|
74,159 |
Restructuring and other |
(1,032) |
|
(8,230) |
|
(7,206) |
|
(22,377) |
Non-GAAP Operating Expenses |
$ 65,504 |
|
$ 75,939 |
|
$ 119,341 |
|
$ 152,819 |
GAAP Operating Expenses as a % of GAAP Revenue |
58.8 % |
|
53.2 % |
|
61.6 % |
|
35.6 % |
Non-GAAP Operating Expenses as a % of Non-GAAP Revenue |
51.4 % |
|
45.6 % |
|
52.1 % |
|
48.3 % |
|
|
|
|
|
|
|
|
GAAP Operating Loss |
$ (36,716) |
|
$ (61,068) |
|
$ (82,466) |
|
$ (49,168) |
Amortization of acquired intangible assets |
145 |
|
168 |
|
280 |
|
339 |
Stock-based compensation |
3,763 |
|
4,510 |
|
9,076 |
|
12,458 |
Net merger, acquisition and divestiture expense (income) |
4,768 |
|
(43) |
|
5,718 |
|
(74,159) |
Restructuring and other |
1,032 |
|
8,230 |
|
8,864 |
|
22,377 |
Non-GAAP Operating Loss |
$ (27,008) |
|
$ (48,203) |
|
$ (58,528) |
|
$ (88,153) |
GAAP Operating Margin |
(28.8) % |
|
(36.7) % |
|
(36.0) % |
|
(15.5) % |
Non-GAAP Operating Margin |
(21.2) % |
|
(29.0) % |
|
(25.5) % |
|
(27.9) % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued |
|||||||
(in thousands, except per share amounts) |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
For the six months ended |
||||
|
|
|
|
|
|
|
|
GAAP Income Tax (Benefit) Expense |
$ (523) |
|
$ 729 |
|
$ (65) |
|
$ 837 |
Tax effect of non-GAAP adjustments |
178 |
|
416 |
|
226 |
|
1,017 |
Other tax adjustments |
922 |
|
(416) |
|
791 |
|
(608) |
Non-GAAP Income Tax Expense |
$ 577 |
|
$ 729 |
|
$ 952 |
|
$ 1,246 |
|
|
|
|
|
|
|
|
GAAP Net Loss |
$ (22,808) |
|
$ (70,646) |
|
$ (110,081) |
|
$ (62,039) |
Amortization of acquired intangible assets |
145 |
|
168 |
|
280 |
|
339 |
Stock-based compensation |
3,763 |
|
4,510 |
|
9,076 |
|
12,458 |
Net merger, acquisition and divestiture expense (income) |
4,768 |
|
(43) |
|
5,718 |
|
(74,159) |
Restructuring and other |
1,032 |
|
8,230 |
|
8,864 |
|
22,377 |
(Gain) loss on strategic investments |
(394) |
|
- |
|
(394) |
|
375 |
Debt issuance costs |
5,627 |
|
238 |
|
18,636 |
|
477 |
Income tax effect |
(1,100) |
|
- |
|
(1,017) |
|
(409) |
Non-GAAP Net Loss |
$ (8,967) |
|
$ (57,543) |
|
$ (68,918) |
|
$ (100,581) |
|
|
|
|
|
|
|
|
GAAP Net Loss Per Diluted Share |
$ (0.68) |
|
$ (2.41) |
|
$ (3.41) |
|
$ (2.16) |
Amortization of acquired intangible assets |
- |
|
0.01 |
|
0.01 |
|
0.01 |
Stock-based compensation |
0.11 |
|
0.15 |
|
0.28 |
|
0.43 |
Net merger, acquisition and divestiture expense (income) |
0.14 |
|
- |
|
0.17 |
|
(2.58) |
Restructuring and other |
0.03 |
|
0.28 |
|
0.27 |
|
0.78 |
(Gain) loss on strategic investments |
(0.01) |
|
- |
|
(0.01) |
|
0.01 |
Debt issuance costs |
0.17 |
|
0.01 |
|
0.58 |
|
0.02 |
Income tax effect |
(0.03) |
|
- |
|
(0.03) |
|
(0.01) |
Non-GAAP Net Loss Per Diluted Share |
$ (0.27) |
|
$ (1.96) |
|
$ (2.14) |
|
$ (3.50) |
|
|
|
|
|
|
|
|
Number of shares used in diluted per share calculation |
33,410 |
|
29,309 |
|
32,259 |
|
28,740 |
|
|
|
|
|
|
|
|
Supplemental Information |
|
|
|
|
|
|
|
Days sales outstanding |
40 |
|
37 |
|
|
|
|
GAAP Days in inventory |
90 |
|
67 |
|
|
|
|
Non-GAAP Days in inventory(1) |
90 |
|
67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/irobot-reports-second-quarter-2025-financial-results-302523929.html
SOURCE